Why do i get rls every night

Overview

Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological sensorimotor disorder characterized by an irresistible urge to move the legs, typically accompanied by uncomfortable sensations. First medically described by English physician Thomas Willis in 1672, the condition was formally named and characterized by Swedish neurologist Karl-Axel Ekbom in 1945, who published the first comprehensive study of 34 cases. RLS affects approximately 7-10% of the adult population in Western countries, with prevalence increasing with age—affecting up to 20% of people over 80. The condition follows a circadian pattern, with symptoms typically worsening in the evening and at night, particularly during periods of rest or inactivity. Diagnosis follows the International Restless Legs Syndrome Study Group criteria established in 1995 and updated in 2014, requiring four essential features including the urge to move legs, worsening at rest, relief with movement, and circadian pattern. The condition exists in primary (idiopathic) and secondary forms, with secondary RLS associated with conditions like iron deficiency, kidney failure, pregnancy (affecting up to 30% of pregnant women), and certain medications.

How It Works

The nighttime worsening of RLS symptoms involves complex neurobiological mechanisms centered on dopamine and iron regulation in the brain. Dopamine, a neurotransmitter involved in movement control, follows a circadian rhythm with levels naturally decreasing in the evening. In RLS patients, this normal dopamine fluctuation becomes problematic due to underlying dysfunction in the dopaminergic system, particularly in the A11 diencephalospinal pathway that projects to the spinal cord. Iron plays a crucial role as a cofactor for tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis. When brain iron stores are low (measured via cerebrospinal fluid ferritin levels below 50 μg/L), dopamine production becomes impaired. This iron-dopamine connection explains why symptoms worsen at night: as dopamine levels naturally decline with circadian rhythms, the already compromised system becomes insufficient to suppress abnormal sensory signals. Additionally, the suprachiasmatic nucleus (the brain's master clock) influences these processes through its connections to dopamine-producing areas. During sleep onset, reduced sensory input and decreased motor activity may unmask underlying sensorimotor dysfunction, while the body's natural decrease in core temperature and changes in melatonin secretion may further exacerbate symptoms through poorly understood mechanisms.

Why It Matters

Nighttime RLS significantly impacts sleep quality and overall health, with 88% of patients reporting sleep disturbances and 60% experiencing daytime fatigue. The condition reduces total sleep time by an average of 1-2 hours per night and increases risk of developing clinical insomnia. Beyond sleep disruption, RLS associates with cardiovascular consequences—studies show a 39% increased risk of hypertension and 2-3 times higher risk of cardiovascular disease in severe cases, possibly due to sympathetic nervous system activation from frequent leg movements. The economic burden is substantial, with RLS patients incurring 25-30% higher healthcare costs annually compared to matched controls, totaling billions in direct and indirect costs. Quality of life measures show RLS impacts physical and mental health similarly to other chronic conditions like diabetes and osteoarthritis. Proper diagnosis and treatment can reduce symptoms by 50-70% in responsive patients, highlighting the importance of recognizing the circadian pattern for effective management. Research continues to explore the genetic basis (with 6 identified susceptibility loci) and potential links to other neurological conditions.